Should we tolerate tolerability as an objective in early drug development?
Editors' Report for 2006
Use of statins and risk of haematological malignancies
Development of oral anticoagulants
Randomized exposure-controlled trials; impact of randomization and analysis strategies
Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath®) in patients with chronic lymphocytic leukaemia and its link to treatment response
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women
Effect of renal impairment on the pharmacokinetics of exenatide
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size
A pharmacokinetic model for L-carnitine in patients receiving haemodialysis
SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients
Foundation year 1 doctors and clinical pharmacology and therapeutics teaching. A retrospective view in light of experience
Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards
Primary care prescribing patterns in Ireland after the publication of large hypertension trials
Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole
CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea
Homeopathy is safe and does not lack positive evidence in clinical trials
Scottish GPs use of homeopathy
Homeopathy is safe and does not lack positive evidence in clinical trials/Scottish GPs use of Homeopathy
Heart Rate Slowing by If Current Inhibition